找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Identification of Biomarkers, New Treatments, and Vaccines for COVID-19; Paul C. Guest Book 2021 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: Nixon
11#
發(fā)表于 2025-3-23 12:24:09 | 只看該作者
Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reason explanations for this disparity are not clear. Thus, we attempted to identify rational explanations about age-related differences as reported in different studies. Given the incomplete data on SARS-CoV-2, some information has been gathered from other studies of earlier coronavirus or influenza outb
12#
發(fā)表于 2025-3-23 14:35:31 | 只看該作者
13#
發(fā)表于 2025-3-23 20:58:38 | 只看該作者
14#
發(fā)表于 2025-3-23 22:44:19 | 只看該作者
15#
發(fā)表于 2025-3-24 05:10:07 | 只看該作者
16#
發(fā)表于 2025-3-24 08:14:43 | 只看該作者
How Do We Manage Breastfeeding During the COVID-19 Pandemic? including sexual and reproductive health, publishing in all of these areas has increased lately. One aspect that requires basing on scientific evidence is breastfeeding. There are some controversies in the literature on the breastfeeding management in confirmed COVID-19 mothers. Breast milk is exce
17#
發(fā)表于 2025-3-24 12:21:45 | 只看該作者
18#
發(fā)表于 2025-3-24 16:42:15 | 只看該作者
Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review study the effect of ozone therapy on COVID-19 patients and the available supporting evidence. Electronic databases including MEDLINE (via PubMed), EMBASE, Cochrane Library (CENTRAL), and TRIP, clinical trial registries, and preprint sources were searched for published evidence-based articles. In ad
19#
發(fā)表于 2025-3-24 22:10:53 | 只看該作者
20#
發(fā)表于 2025-3-25 02:44:43 | 只看該作者
Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19)n the oral and nasal cavities, agents that act on these two areas have the potential for large therapeutic and prophylactic benefit. A literature review was conducted to elucidate the possible agents useful in treatment of SARS-CoV-2. These agents were evaluated for their current applications, adver
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 06:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
景宁| 汉寿县| 鲁甸县| 读书| 南漳县| 清徐县| 临城县| 锦屏县| 绩溪县| 兴文县| 盐亭县| 新安县| 开化县| 视频| 商南县| 临邑县| 海盐县| 合山市| 淮南市| 江都市| 湖口县| 杭锦后旗| 湟源县| 临颍县| 屏东市| 蒙城县| 西贡区| 蕲春县| 永寿县| 泰州市| 泾川县| 鄂尔多斯市| 海兴县| 安徽省| 郓城县| 台山市| 红河县| 容城县| 河西区| 夏河县| 伊川县|